← Open Payments lookup

CHRISTABEL LARTEY: Open Payments

NPI 1962762237 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,917 in 73 payments from 11 companies in 2025. Trend: 2023 $2,080 · 2024 $2,746 · 2025 $1,917

Food & beverage: $1,917
CompanyPaymentsAmount
Alkermes, Inc.15$389
ABBVIE INC.15$302
Otsuka America Pharmaceutical, Inc.7$280
E.R. Squibb & Sons, L.L.C.11$227
Janssen Pharmaceuticals, Inc6$187
Vanda Pharmaceuticals Inc.5$131
Braeburn Inc.1$109
Neurocrine BioSciences, Inc.4$97
Lundbeck LLC5$95
Teva Pharmaceuticals USA, Inc.3$69

Products named: VRAYLAR, ARISTADA, COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, REXULTI, LYBALVI, FANAPT.

Industry payments across VA — which companies pay providers there.